Coming up to nearly 6 months since this update on closed angle glaucoma and whether ITrackadvance will become indicated and have an Asian monopoly of sorts, which is particularly significant for China.
https://announcements.asx.com.au/asxpdf/20231025/pdf/05wg71vjr0cqr1.pdf
They should have both peer review progress and substantially more patients having reached 12 month mark by now.
I only looked back on it as they plugged heavily the 2023 Singapore APACRS conference and the 2024 one this year is in China
https://nova-eye.com/uploads/Nova-Eye-Medical-Media-Release-APACRS-2023-8June2023.pdf
from a quick glance at the China conference not much iTrack in the program but given their study is in progress without definite outcomes maybe that’s understandable
https://apacrs2024.org
in the meantime China is not showing much progress saleswise but they are only selling old Itrack. The recent presentation states ITrackadvance approval pending so it would be good to get a timeframe.
in summary China prob a good 2 years behind US until it hits high growth for itrackadvance but when it kicks in could have an afterburner growth dividend to build off what will be then known US growth for those looking 2/3/4/5 years out.
- Forums
- ASX - By Stock
- Nova Eye Medical (EYE) Discussion
Coming up to nearly 6 months since this update on closed angle...
-
-
- There are more pages in this discussion • 589 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.82M |
Open | High | Low | Value | Volume |
23.0¢ | 23.5¢ | 22.5¢ | $14.15K | 61.77K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23417 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 100448 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 23417 | 0.225 |
3 | 170390 | 0.220 |
3 | 164670 | 0.215 |
11 | 396185 | 0.210 |
5 | 66036 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 100448 | 2 |
0.245 | 12081 | 1 |
0.250 | 200000 | 3 |
0.255 | 125000 | 2 |
0.260 | 25992 | 2 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online